Organigram Global Inc. OGI

Organigram Global (NASDAQ:OGI) outlined a strategy centered on protecting its Canadian market position while increasing profitability, expanding internationally through its Sanity Group acquisition, improving manufacturing efficiency and applying stricter capital-allocation discipline. At its 2026

TORONTO, September 30, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram") is pleased to announce that the 2026 OG Investor Session will premiere today, September 30, 2026, at 4:00 p.m. ET on the Company's X account at https://x.com/Organigram_Inc.

TORONTO, September 02, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session.

TORONTO, August 20, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) ("Organigram" or the "Company") today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH ("Sanity") and the alignment of leadership, operations and market development activities across the combined organization.

Key Takeaways; Cannabis Sector Curaleaf Holdings Announced Intention to Launch a Hostile Takeover Bid to Acquire Aurora Cannabis Organigram Posted Record Quarter as Sanity Group Acquisition Fueled Global Expansion Key Takeaways; Psychedelic Sector Optimi Health Set Up US$100 Million Equity Facility to Support Growth Definium Therapeutics’ Phase 3 Trial Delivered Strong Results for DT120 in […]

Moby summary of Organigram Global Inc.'s Q3 2026 earnings call

International expansion drives 49% revenue surge and record profitability, with full-year guidance raised above $350 million.

TORONTO, August 11, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH ("Sanity" or "Sanity Group"), today announced its results for the third quarter ended June 30, 2026 ("Q3 Fiscal 2026" or "Q3").

TORONTO, August 04, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH ("Sanity"), announced today it will report earnings results for its third quarter ended June 30, 2026, on Tuesday, August 11, 2026, prior to market open.

TORONTO, July 20, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH ("Sanity"), today provided a business update highlighting initial operating performance from Sanity, continued strength in its Canadian business, and upcoming investor engagement.

Organigram Global Inc (NASDAQ:OGI) is one of the best CBD stocks to buy right now. Analysts expect Organigram Global shares to explode by more than 140% over the next 12 months. On May 12, Organigram Global Inc (NASDAQ:OGI) reported its March quarter results and issued guidance for 2026 revenue. The March quarter report showed net […]

OrganiGram Holdings (TSX:OGI) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. View the webcast at https://events.q4inc.com/analyst/574618022?pwd=FVnom6fM Summary Organigram Global Inc reported a challenging Q2 with a decline in net revenue to 59.8 million, primarily due to is

OrganiGram Holdings (NASDAQ:OGI) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. The full earnings call is available at https://events.q4inc.com/analyst/574618022?pwd=FVnom6fM Summary Organigram Global Inc faced challenges in Q2 with Canadian recreational market growth slowing a